Trial Profile

A Phase, I Prospective, Randomized, Double-Blinded, Placebo-controlled, Trial to Evaluate the Safety and Potential Efficacy of Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Laromestrocel (Primary)
Indications Alzheimer's disease
Focus Adverse reactions
Sponsors Longeveron

Most Recent Events

14 Apr 2022 According to a Longeveron media release, data from this study will be presented at 3rd Latinos & Alzheimers Symposium
31 Mar 2022 Results published in the Longeveron Media Release.
31 Mar 2022 According to a Longeveron media release, results from the study were published in the Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com